YES AMAZING YES and we with the @aclu_nationwide : "We are happy the FDA has increased pharmacy access to this safe and effective medication, relieving one of the agency's needless burdens on mifepristone patients. But leading medical groups have long called for outright elimination of the FDA's special restrictions on mifepristone, which obstruct abortion and miscarriage patients from accessing the time-sensitive health care they need without a corresponding safety benefit. As abortion access evaporates across the country, and communities of color and people with fewer resources disproportionately suffer the severe medical consequences of forced pregnancy, the FDA's actions - while inching toward progress - fall short of what science and justice demand." Posted @withregram • @nytimes For the first time, retail pharmacies, including corner drugstores and major chains like CVS and Walgreens, will be allowed to offer abortion pills in the U.S. under a regulatory change made Tuesday by the Food and Drug Administration. The action could significantly expand access to abortion through medication. Until now, mifepristone — the first pill used in the two-drug medication abortion regimen — could be dispensed only by two mail-order pharmacies or by specially certified doctors or clinics. Under the new FDA rules, patients will still need a prescription from a certified health provider, but any pharmacy that agrees to accept those prescriptions and abide by certain other criteria can dispense the pills in its stores and by mail order. The FDA did not issue a formal statement on Tuesday but updated a web page to reflect the decision. The change comes as abortion pills, already used in more than half of pregnancy terminations in the U.S., are becoming even more sought after in the aftermath of last year’s Supreme Court decision overturning the federal right to abortion. With conservative states banning or sharply restricting abortion, the pills have increasingly become the focus of political and legal battles, which may influence a pharmacy’s decision about whether to dispense the medication. Tap the link in our bio to read more about the FDA’s regulatory change.